-
6:00am • Poster Setup
-
7:00am • PO095: Impact of Video Education on Patient Knowledge, Anxiety, and Satisfaction in Selective Laser Trabeculoplasty
-
7:00am • PO075: Quantitative Evaluation of Natural Drug therapy Options for Glaucoma: A Systematic Review and Meta-Analysis.
-
7:00am • PO084: Engineering a Bioartificial Tenon’s Capsule Tissue Model for High Throughput Drug Testing
-
7:00am • PO102: The Effect of Topical Difluprednol on Intraocular Pressure in Patients with Uveitis
-
7:00am • PO101: Bimatoprost Sustained-Release Implant (Bimatoprost SR) Responder Rates in Patients With Glaucoma or Ocular Hypertension: Phase 3 Study Results at Primary Database Lock
-
7:00am • Poster Viewing: Traditional Surgery, Sustained Delivery, New Drugs, IOP Evaluation
-
7:00am • PO078: Intraocular Pressure Goals in Severe Secondary Glaucoma
-
7:00am • PO068: The Steroid Response as a Contributor to the Hypertensive Phase After a Glaucoma Drainage Device Implant
-
7:00am • PO047: Uveitic Glaucoma: A 10-year Retrospective and Risk Factors For Requiring Filtering Surgery
-
7:00am • PO067: Intraocular Pressure Spikes After Cataract Surgery in Glaucoma and Non-glaucoma Patients
-
7:00am • PO104: Changes in Intraocular Pressure and Angle Structures After Pupillary Dilation in Patients with Primary Angle Closure Suspect and Visually Significant Cataract
-
7:00am • PO062: Predictive Factors for Microcystic Macular Edema in Glaucoma
-
7:00am • PO074: Efficacy & Safety of Standalone Ab Interno Gelatin Microstent Implantation with MMC vs. Trabeculectomy with MMC: 3 Years Follow-Up
-
7:00am • PO099: The Efficacy and Safety Profile of Latanoprostene Bunod 0.024% in Glaucoma Treatment: Real-World Outcomes
-
7:00am • PO079: Long-Term IOP Lowering After A Single Bimatoprost SR Administration in a Phase 1/2 Study: Relationship to Early IOP Response
-
7:00am • PO066: Needle Revision of Filtering Bleb with Mitomycin C: Outcomes and Safety Profile
-
7:00am • PO064: The Clinical Significance of Vertical Anterior Corneal Striae in Hypotony
-
7:00am • PO054: Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma
-
7:00am • PO073: Outcomes of Glaucoma Surgery Combined With Scleral Fixation of an Intraocular Lens Using Gore-Tex Suture
-
7:00am • PO063: Risk Factors for Glaucoma Drainage Device Failure in the Pediatric Population
-
7:00am • PO097: Targeted Delivery via Intracameral Administration Versus Topical Dose of 14C-latanoprost in Animal Models.
-
7:00am • PO080: Factors Associated with Laser Trabeculoplasty Efficacy and Failure: IRIS Registry Analysis
-
7:00am • Poster Presentation Session: Traditional Surgery, Sustained Delivery, New Drugs, IOP Evaluation
-
7:00am • PO070: Does Tube-Iris Touch Cause Anterior Chamber Inflammation in Patients with Ahmed Valve Implantation?
-
7:00am • PO087: Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation
-
7:00am • PO085: A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG)
-
7:00am • PO098: Efficacy and Safety of Netarsudil 0.02% in Patients with Chronic Angle-closure Glaucoma Versus Primary Open-angle Glaucoma
-
7:00am • PO086: Comparison of Extraocular and Intraocular Pressure Transducers for Measurement of Transient IOP Fluctuations Using Continuous Wireless Telemetry
-
7:00am • PO094: Convolutional Neural Networks for Fast and Accurate Ophthalmic Medication Bottle Classification
-
7:00am • PO089: The Effects of Hypotension and Steep Trendelenburg Positioning on Optical Coherence Tomography Testing
-
7:00am • PO061: Higher Rates of Recurrent Tube Exposure with Anti-VEGF Therapy in Patients with Macular Degeneration
-
7:00am • PO077: Topical, Injectable and Implantable Slow Release Drug Delivery Platforms for Glaucoma Patients
-
7:00am • PO082: Sources of Variability in Mean Intraocular Pressure (IOP) in Nonhuman Primates Instrumented with Continuous Telemetry
-
7:00am • PO051: Long-Term Outcomes of Primary Trabeculectomy Versus Combined Phacoemulsification-Trabeculectomy Using Automated Electronic Health Record Data Extraction
-
7:00am • PO072: Surgical Outcomes of Neovascular Glaucoma
-
7:00am • PO055: Progression to No Light Perception Vision is Equally Likely with Valved and Non-Valved Tube Shunts in Neovascular Glaucoma
-
7:00am • PO092: Real-world use of Latanoprostene Bunod 0.024% in Patients with Glaucoma or Ocular Hypertension Naïve to Pharmacotherapy
-
7:00am • PO076: Development of an Injectable, Space-filling Thermosensitive Dydrogel as a Subconjunctival Bleb Scaffold and Sustained Release Drug Depot
-
7:00am • PO071: PAUL Glaucoma Implant in the Surgical Management of Refractory Glaucoma: 12-month Safety and Efficacy Outcomes of a Novel Aqueous Shunt Implant.
-
7:00am • PO083: PROSE Devices in Glaucoma Patients
-
7:00am • PO048: Incidence of Corneal Transplant Graft Failure with Glaucoma Drainage Device Placed in the Anterior Chamber compared to the Ciliary Sulcus
-
7:00am • PO056: Surgical Outcomes Assessment of Glaucoma Tube Shunt Implantation: an Electronic Health Records Analysis
-
7:00am • PO065: Effectiveness of a New Blebless Tube Shunt in Glaucomatous Eyes with Uncontrolled IOP
-
7:00am • PO100: Intraocular Pressure Measurement Using Goldmann Applanation Aonometry by Ophthalmic Technicians - A Quality Improvement Initiative
-
7:00am • PO091: Safety and Effectiveness of Argon Laser Peripheral Iridoplasty (ALPI) in a Large Group of Narrow Angle Patients who Failed Laser Peripheral Iridotomy (LPI)
-
7:00am • PO090: Profile of IOP Response to Bimatoprost Sustained-Release Implant (Bimatoprost SR) Before Added Treatment With Topical Medication: Phase 3 Study Results
-
7:00am • PO069: Effect of Phacoemulsification on Intraocular Pressure in African American Versus Caucasian Patients with Primary Open Angle Glaucoma
-
7:00am • PO081: Effect of Bimatoprost SR on IOP in Patients Previously Treated With 0, 1, or ≥2 Topical IOP-Lowering Medications: Results of Phase 3 Study at Primary Database Lock
-
7:00am • PO103: Tear Film Characteristics in Patients on Topical Glaucoma Therapy
-
7:00am • PO049: Early Surgeon Experience with a New Valveless Glaucoma Drainage Device
-
7:00am • PO050: Factors Associated with Trabeculectomy Failure Following Phacoemulsification
-
7:00am • PO088: Patient Experience With Intraocular Pressure Measurement by Tonopen and Icare
-
7:00am • PO052: The Relationship of Patient Distance to Postoperative Care on Follow-up Attrition and Glaucoma Surgery Outcomes.
-
7:00am • PO059: Diplopia in Patients with Baerveldt 250 and 350, and Ahmed FP7 Glaucoma Drainage Devices
-
7:00am • PO096: Aqueous Humor Proteomic Changes Correlated with Visual Field Index Parameters in Glaucomatous Optic Neuropathy
-
7:00am • PO053: Direct Cyclopexy for Postraumatic Cyclodyalisis: Clinical Characteristics and Outcomes
-
7:00am • PO057: Safety and Efficacy Outcomes of Modern Trabeculectomy with Low Dose Injected Mitomycin C with Planned Laser Suturelysis
-
7:00am • PO058: Three Year Outcomes of Trabecular Micro-Bypass Stents (iStent Inject) Stratified by Prior Glaucoma Surgery
-
7:00am • PO093: Incorporation of the First Nitric Oxide Donating Prostaglandin, Latanoprostene Bunod, into Clinical Practice
-
7:00am • PO060: The Requirement of Additional Glaucoma Surgery After Glaucoma Drainage Device Surgery in Patients with Open-angle, Angle-closure, Neovascular, and Pseudoexfoliative Glaucoma
-
5:00pm • Poster Teardown
-
6:00am • Poster Setup
-
7:00am • PO129: Glaucoma-Related Malpractice Litigation: A Review of the WestLaw Database
-
7:00am • PO150: Clinical Validation of a Deep Learning Classifier for Detecting Gonioscopic Angle Closure on Anterior Segment OCT Images
-
7:00am • PO144: Pattern Electroretinogram as a Novel Biomarker of Retinal Ganglion Cell Function: Correlation to Foveal Avascular Zone in Preperimetric Glaucoma
-
7:00am • PO146: Glaucoma Caregivers
-
7:00am • PO111: Pseudo-glaucomatous Cupping and Impaired Visual Processing in Cerebral Palsy
-
7:00am • PO141: Microvasculature of the Optic Nerve Head and Peripapillary Region in Eyes with Glaucomatous Paracentral Visual Field Loss
-
7:00am • PO127: Prevalence of Autoimmune Diseases in Primary Open Angle Glaucoma (POAG) Patients Undergoing Ophthalmic Surgeries
-
7:00am • PO145: Diagnostic Capability of PERG and Three Circumpapillary SD-OCT Diameter RNFL Thickness Scans in Pre-Perimetric Glaucoma
-
7:00am • Poster Viewing: VF, Imaging, Diagnostics, Social/Financial/Personal Determinants of Health
-
7:00am • PO136: Barriers to Glaucoma Follow-up Care in a West African Population
-
7:00am • PO128: Update on the Association Between 24-Hour Blood Pressure and Optic Disc Hemorrhage in Glaucomatous Eyes
-
7:00am • PO110: Does Short Term Treatment in the Ocular Hypertension Treatment Study (OHTS) Improve the Visual Field?
-
7:00am • PO138: Travel Time to Glaucoma Specialists' Offices in Florida: A Geo-Demographic Service Coverage Analysis
-
7:00am • PO108: Assessing Retinal Blood Flow Dysregulation in Glaucoma by Erythrocyte Mediated Angiography Velocimetry (EMAv)
-
7:00am • PO106: Glaucomatous Neurodegeneration in Schizophrenia: Morphometric Analysis of the Retinal Ganglion and Photoreceptor Complexes Using Optical Coherence Tomography In Vivo
-
7:00am • PO117: Assessing Glaucoma Knowledge in Patients Visiting the Glaucoma Clinic Compared to Other Ophthalmology Clinics
-
7:00am • PO143: The Use of Health Information Technology by U.S. Patients with Glaucoma
-
7:00am • PO115: Asymmetry of Macular Vessel Density in Bilateral Early Primary Open-Angle Glaucoma with Unilateral Central 10-2 Visual Field Loss
-
7:00am • PO134: Standardized quantification of episcleral venous flow using Erythrocyte-Mediated Angiography
-
7:00am • PO120: Diminished Facial Recognition in Glaucoma Patients with Good Central Visual Acuity
-
7:00am • Poster Presentation Session: VF, Imaging, Diagnostics, Social/Financial/Personal Determinants of Health
-
7:00am • PO125: The Effectiveness of Resident Diagnosis and Follow up of Glaucoma Suspect – A Retrospective Review
-
7:00am • PO109: Effects of Non-Insulin Dependent Diabetes Mellitus on Primary Open Angle Glaucoma and Peripapillary Microvasculature Density (VD)
-
7:00am • PO148: Patient Interest and Willingness to Pay for Teleophthalmology Remote Consultations
-
7:00am • PO139: Ability to Predict Visual Field Damage Using Patient Reported Symptoms
-
7:00am • PO105: Medication Load and Comorbidities in Glaucoma
-
7:00am • PO149: Improving Compliance and Physician-Patient Dialogue in Glaucoma
-
7:00am • PO132: Cost Analysis of a Tele-Ophthalmology Mobile Screening Unit
-
7:00am • PO140: Comparison of Peripapillary and Macular Blood Flow in Patients with Pseudoexfoliation Syndrome, Primary Open Angle Glaucoma and Healthy Controls
-
7:00am • PO131: Healthcare Resource Utilization and Costs Related to Ocular Hypertension and Open-angle Glaucoma by Disease Severity
-
7:00am • PO112: Pictorializing What People with Glaucoma Perceive in Regions of Visual Field Loss: Results From a Novel iPad App
-
7:00am • PO147: Comparison of Optical Coherence Tomography Parameters at the Optic Disc and Macula Between Eyes with Acute Primary Angle Closure and Their Fellow Eyes.
-
7:00am • PO121: The Effectiveness of Resident Use of OHTS Criteria in Treatment of Ocular Hypertension Patients
-
7:00am • PO119: Impact of the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Installation Technique and Self-efficacy
-
7:00am • PO135: Foveal Avascular Zone (FAZ) in Glaucoma
-
7:00am • PO123: Surgical Cancellations in Glaucoma Practice: Causes, Delays, and Effect on Patient Care and Revenue
-
7:00am • PO126: Ultrasound Biomicroscopy in Peters' Anomaly
-
7:00am • PO107: Peripapillary Region OCT-A of Patients with POAG and CACG
-
7:00am • PO113: Differences in Outflow Channels Between Two Eyes of Unilateral Primary Congenital Glaucoma
-
7:00am • PO133: Impact of the Support, Educate, Empower (SEE) Glaucoma Coaching Program on Glaucoma Medication Adherence – A Pilot Study
-
7:00am • PO116: Health Literacy in Glaucoma - The Singapore Glaucoma Health Literacy Scale
-
7:00am • PO122: Glaucoma Patient Perceptions of Marijuana Use for the Treatment of Glaucoma
-
7:00am • PO142: Reference Standard Optic Disc Images Associated with Threshold Glaucomatous Visual Field Loss Determined by Archetypal Analysis
-
7:00am • PO137: Assessing a Novel Head Mounted Device Perimeter and Its Correlation with Standard Automated Perimeter
-
7:00am • PO114: Access to Medications Among Patients with Glaucoma
-
7:00am • PO130: Guidelines-driven IOP Targets and Visual Field Progression
-
7:00am • PO124: Mental Stress Influence on Intra-ocular Pressure and Visual Field
-
7:00am • PO118: Marijuana and Glaucoma: A Social Media Content Analysis
-
7:00am • PO151: Predicting Risk of Rapid Visual Field Progression Based on the Initial Visual Field Test Using Machine Learning
-
4:05pm • Poster Teardown
